Certolizumab Pegol Inhibits Radiographic Progression at 16 Weeks of Treatment. Results from Two RCTs (RAPID 1 And 2)
Publication
, Conference
Pope, J; van der Heijde, D; Weinblatt, M; Landewe, R; Goel, N; Wells, AF; Fleischmann, RM
Published in: JOURNAL OF RHEUMATOLOGY
November 1, 2009
Duke Scholars
Published In
JOURNAL OF RHEUMATOLOGY
ISSN
0315-162X
Publication Date
November 1, 2009
Volume
36
Issue
11
Start / End Page
2603 / 2604
Location
Kananaskis, CANADA
Publisher
J RHEUMATOL PUBL CO
Conference Name
64th Annual Meeting/17th Winter Workshop of the Canadian-Rheumatology-Association
Related Subject Headings
- Arthritis & Rheumatology
- 3204 Immunology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1107 Immunology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Pope, J., van der Heijde, D., Weinblatt, M., Landewe, R., Goel, N., Wells, A. F., & Fleischmann, R. M. (2009). Certolizumab Pegol Inhibits Radiographic Progression at 16 Weeks of Treatment. Results from Two RCTs (RAPID 1 And 2). In JOURNAL OF RHEUMATOLOGY (Vol. 36, pp. 2603–2604). Kananaskis, CANADA: J RHEUMATOL PUBL CO.
Pope, Janet, Desiree van der Heijde, Michael Weinblatt, Robert Landewe, Niti Goel, Alvin F. Wells, and Roy M. Fleischmann. “Certolizumab Pegol Inhibits Radiographic Progression at 16 Weeks of Treatment. Results from Two RCTs (RAPID 1 And 2).” In JOURNAL OF RHEUMATOLOGY, 36:2603–4. J RHEUMATOL PUBL CO, 2009.
Pope J, van der Heijde D, Weinblatt M, Landewe R, Goel N, Wells AF, et al. Certolizumab Pegol Inhibits Radiographic Progression at 16 Weeks of Treatment. Results from Two RCTs (RAPID 1 And 2). In: JOURNAL OF RHEUMATOLOGY. J RHEUMATOL PUBL CO; 2009. p. 2603–4.
Pope, Janet, et al. “Certolizumab Pegol Inhibits Radiographic Progression at 16 Weeks of Treatment. Results from Two RCTs (RAPID 1 And 2).” JOURNAL OF RHEUMATOLOGY, vol. 36, no. 11, J RHEUMATOL PUBL CO, 2009, pp. 2603–04.
Pope J, van der Heijde D, Weinblatt M, Landewe R, Goel N, Wells AF, Fleischmann RM. Certolizumab Pegol Inhibits Radiographic Progression at 16 Weeks of Treatment. Results from Two RCTs (RAPID 1 And 2). JOURNAL OF RHEUMATOLOGY. J RHEUMATOL PUBL CO; 2009. p. 2603–2604.
Published In
JOURNAL OF RHEUMATOLOGY
ISSN
0315-162X
Publication Date
November 1, 2009
Volume
36
Issue
11
Start / End Page
2603 / 2604
Location
Kananaskis, CANADA
Publisher
J RHEUMATOL PUBL CO
Conference Name
64th Annual Meeting/17th Winter Workshop of the Canadian-Rheumatology-Association
Related Subject Headings
- Arthritis & Rheumatology
- 3204 Immunology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1107 Immunology
- 1103 Clinical Sciences